{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:35:14Z","timestamp":1777934114367,"version":"3.51.4"},"reference-count":32,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong province","doi-asserted-by":"crossref","award":["ZR2023QH039"],"award-info":[{"award-number":["ZR2023QH039"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1080\/15563650.2024.2316144","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:06:55Z","timestamp":1709561215000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Sex differences in the susceptibility to valproic acid-associated liver injury in epileptic patients"],"prefix":"10.1080","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-3085","authenticated-orcid":false,"given":"Linfeng","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Yantai Yuhuangding Hospital","place":["Yantai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of life science, Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0841-x"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190329145428"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.32.4.428"},{"issue":"5","key":"e_1_3_4_5_1","first-page":"193","article-title":"The prevalence of obesity and metabolic syndrome in paediatric patients with epilepsy treated in monotherapy with valproic acid","volume":"61","author":"Carmona-Vazquez CR","year":"2015","unstructured":"Carmona-Vazquez CR, Ruiz-Garcia M, Pena-Landin DM, et\u00a0al. The prevalence of obesity and metabolic syndrome in paediatric patients with epilepsy treated in monotherapy with valproic acid. Rev Neurol. 2015;61(5):193\u2013201.","journal-title":"Rev Neurol"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0251-3"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.60.2.0017"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061516-045037"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000485089"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi185"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152585"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq294"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.02.009"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23668"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000574"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.5.435"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-9236(03)00014-6"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111066"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.056705"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-013-9323-3"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12550"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2016.06.002"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2014.12.007"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2015.01.002"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2015.03.001"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111802"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2022.103967"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2011.04.014"},{"issue":"2","key":"e_1_3_4_29_1","first-page":"219","article-title":"A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics","volume":"25","author":"Tang W","year":"1997","unstructured":"Tang W, Abbott FS. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics. Drug Metab Dispos. 1997;25(2):219\u2013227.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"e_1_3_4_30_1","first-page":"525","article-title":"Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans","volume":"19","author":"Kassahun K","year":"1991","unstructured":"Kassahun K, Farrell K, Abbott F. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Drug Metab Dispos. 1991;19(2):525\u2013535.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2022.100568"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfs222"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_414_16"}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2024.2316144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T10:21:02Z","timestamp":1738232462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2024.2316144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1080\/15563650.2024.2316144"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2024.2316144","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}